Skip to content
Screener

Charles River Laboratories CRL Other Income (Expense)

Other Income (Expense) at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
-$3.5M+89.3%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
-$415K-202%
Sotera Health logo
Sotera HealthSHC
$2.85M-51.0%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$1.36M-71.1%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
-$200K-107%
Revvity logo
RevvityRVTY
-$25.89M-30.5%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemThree Months Ended / June 27, 2026Three Months Ended / June 28, 2025Six Months Ended / June 27, 2026Six Months Ended / June 28, 2025
Other income (expense)
Interest income1,0321,0972,0652,501
Interest expense(30,340)(29,967)(57,082)(57,851)
Other (expense) income, net(37,410)154(161,540)(12,057)
Income before income taxes53,17071,41823,228107,396
Provision for income taxes53,93018,72538,79028,825
Net income (loss)(760)52,693(15,562)78,571
Less: Net income attributable to noncontrolling interests722367763776

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's other income (expense)?
Charles River Laboratories (CRL) reported other income (expense) of -$37.41M in Q2 2026.
How has Charles River Laboratories's other income (expense) changed year-over-year?
Charles River Laboratories's other income (expense) decreased by 24392.2% year-over-year, from $154K to -$37.41M.
What is the long-term trend for Charles River Laboratories's other income (expense)?
Over 3 years (2021 to 2024), Charles River Laboratories's other income (expense) has grown at a -24.2% compound annual growth rate (CAGR), from -$37.97M to -$16.52M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Charles River Laboratories's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude